3 Nuclear Energy Stocks to Buy Before 2026 Ends

The article highlights three nuclear-power investment approaches for 2026 amid rising global electricity demand, citing 417 operating reactors and 77 under construction worldwide. Cameco offers uranium supply exposure, with demand projected to exceed supply in the early 2030s, while Brookfield Renewable provides a 5.1% yield and roughly 5% annualized distribution growth alongside indirect nuclear exposure through Westinghouse. NuScale Power presents the highest-risk option: it has an approved SMR design and potential projects in Romania and the U.S., but no commercial sale or established revenue base yet.

Analysis

The investable nuclear bottleneck is shifting from reactor announcements to fuel-cycle security: uranium conversion, enrichment, and Western-origin fabrication will capture value years before a new reactor produces power. CCJ's Westinghouse stake adds service and reactor-lifecycle exposure, but it also makes the equity less of a pure uranium-beta vehicle; LEU is the higher-beta U.S. enrichment/HALEU scarcity expression, albeit with materially greater execution and government-contract dependence.

BEP/BEPC should not be treated as a nuclear trade. Its nuclear-linked earnings are too small to offset the far larger sensitivity of renewable-asset valuations to real rates, refinancing costs, power-price contracts, and capital recycling; a falling-rate environment is the more meaningful near-term catalyst. The second-order implication of rising load is stronger contracted-power pricing for existing hydro and renewables, but only where merchant exposure or contract repricing dates allow that demand to flow through.

SMR remains an option on financing and customer conversion, not an operating nuclear-equipment company. A project announcement without committed capital, binding equipment orders, or credible EPC/liability allocation can create a sharp trading rally but does not establish revenue quality; first-of-a-kind cost overruns could force dilution well before recurring cash flow. Consensus enthusiasm also underweights the nearer-term substitute: gas generation, grid equipment, and storage can serve incremental data-center load materially faster than new nuclear builds.

The nuclear theme is structurally credible over 6-18 months, but the article itself is not a fresh catalyst and sentiment is only mildly positive. Near-term upside in CCJ requires spot/term uranium tightening or contracting evidence, while the key reversal signal is utility inventory liquidation, delayed reactor restarts/builds, or renewed availability of Russian fuel-cycle supply to Western buyers.

Key Decisions for Investors

• Maintain a 6-18 month core long in CCJ (or CCO in Canada) only on uranium-price pullbacks; pair against SMR to isolate fuel-cycle cash-flow exposure from speculative reactor-development beta. Thesis fails if CCJ's contracted volume/pricing or Westinghouse EBITDA guidance is cut at the next two reporting cycles.
• Use LEU as a small, higher-volatility satellite rather than SMR for a U.S. fuel-security catalyst; add only after confirming DOE award funding, backlog conversion, and disclosed HALEU delivery economics. Size at less than half a CCJ position because contract timing and execution risk can dominate commodity fundamentals.
• For income/real-asset exposure, prefer BEPC over BEP.UN where tax structure and liquidity are comparable, but buy it as a rates-and-contracted-power trade, not nuclear optionality. Reassess if 10-year real yields rise materially or management funds distributions through incremental equity rather than operating FFO growth.
• Avoid unhedged SMR longs ahead of nonbinding project headlines; a tactical long is justified only after a financed, binding customer contract with milestone payments and a defined construction counterparty. Otherwise, use SMR rallies to fund the CCJ/LEU leg; dilution, a financing delay, or EPC cost escalation is the thesis falsifier.